Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

UNM

Unum Group to Cede $3.8B in LTC Reserves, Shares Drop 4.01%

Unum Group said it will cede $3.8 billion of long-term care statutory reserves to Fortitude Re in a coinsurance deal that cuts its remaining LTC reserve base to about $11.0 billion.

The transaction covers about 50,000 individual LTC policies and represents 26% of Unum’s total LTC statutory reserves and 52% of its individual LTC reserves, based on March 31, 2026 figures. The block also carries about $4.5 billion of best estimate reserves.

After closing, Unum said roughly 70% of its remaining LTC statutory reserves will back group LTC policies, which it said have more basic benefit structures than individual policies.

The deal comes on top of a 2025 LTC reinsurance transaction. Together, the two external transactions reduce Unum’s closed-block LTC statutory reserves by more than $7 billion and cut total LTC statutory reserves by about 40%.

Unum said it expects year-end 2026 holding company liquidity of $1.5 billion to $2.0 billion after the transaction, with leverage of about 25% and RBC of 400% to 425%. The company said the transaction’s earnings impact should be limited to lost investment income and added interest expense tied to financing.

Unum will keep administering the reinsured business, including claims handling and premium rate increase program management. The company said the transaction is expected to close in 2026. The market has reacted to these announcements by moving the company's shares -4.01% to a price of $88.6375. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS